ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,700, issued on July 22, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).
"Medical use of pharmaceutical combination or composition" was invented by Thomas Meinicke (Mittelbiberach, Germany) and Maximilian Von Eynatten (Wiesbaden, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a certain DPP-4 inhibitor for use in combination with metformin in CKD patients."
The patent was filed on Aug. 7, 2023, under Application No. 18/230,693.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=...